UK Markets closed

Heidelberg Pharma AG (0QW5.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
5.54+0.83 (+17.58%)
At close: 05:02PM BST
Full screen
Previous close4.71
Open5.54
Bid0.00 x N/A
Ask0.00 x N/A
Day's range5.54 - 5.54
52-week range5.54 - 5.54
Volume2
Avg. volumeN/A
Market cap142.821M
Beta (5Y monthly)-0.62
PE ratio (TTM)N/A
EPS (TTM)-0.66
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • EQS Group

    Heidelberg Pharma Announces Conclusion of License Agreement with Partner Takeda To Develop an Antibody Targeted Amanitin Conjugate

    Heidelberg Pharma AG / Key word(s): AllianceHeidelberg Pharma Announces Conclusion of License Agreement with Partner Takeda To Develop an Antibody Targeted Amanitin Conjugate09-Sep-2022 / 18:00 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.Ad hoc announcement - Insider information pursuant to Article 17 MARHeidelberg Pharma

  • EQS Group

    Heidelberg Pharma AG Raises Approximately EUR 80 Million From Capital Measure

    DGAP-News: Heidelberg Pharma AG / Key word(s): Corporate ActionHeidelberg Pharma AG Raises Approximately EUR 80 Million From Capital Measure 30.08.2022 / 17:41 CET/CESTThe issuer is solely responsible for the content of this announcement.NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT.PRESS RELEASEHeidelberg Pharm

  • EQS Group

    Heidelberg Pharma AG Launches Rights Issue of up to EUR 80 Million

    DGAP-News: Heidelberg Pharma AG / Key word(s): Corporate ActionHeidelberg Pharma AG Launches Rights Issue of up to EUR 80 Million 12.08.2022 / 12:23 CET/CESTThe issuer is solely responsible for the content of this announcement.NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT.PRESS RELEASEHeidelberg Pharma AG Launch